Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc.（IDRA）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · IDRA · 截至 2022年12月31日
股东结构概览
29
机构持有人数
▲ 1 vs Q3
$1.10M
机构持仓总市值
▼ $168,161 vs Q3
—
总流通股
3.14M
13F 申报持股数
▼ 246,952 vs Q3
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
IDRA 最大股东 · 机构持仓
Q4 2022 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
SIMPLEX TRADING, LLC biological products, (no diagnostic substances) | 2.3K | 6.98% | 6.98% | $0 | Feb 2, 2023 | NEW |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 1.27M | 1.70% | 1.70% | $443.72M | Feb 10, 2023 | ▲ 932 |
JPMORGAN CHASE & CO biological products, (no diagnostic substances) | 200 | 0.61% | 0.61% | $0 | Feb 13, 2023 | — held |
BLACKROCK INC. biological products, (no diagnostic substances) | 439.5K | 0.59% | 0.59% | $153.81M | Feb 13, 2023 | ▼ 185 |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 396.9K | 0.53% | 0.53% | $138.00M | Feb 13, 2023 | ▼ 932 |
CREDIT AGRICOLE S A biological products, (no diagnostic substances) | 200.0K | 0.27% | 0.27% | $70.00M | Feb 13, 2023 | — held |
HOLLENCREST CAPITAL MANAGEMENT biological products, (no diagnostic substances) | 129.0K | 0.17% | 0.17% | $45.15M | Feb 7, 2023 | — held |
STATE STREET CORP biological products, (no diagnostic substances) | 109.7K | 0.15% | 0.15% | $38.41M | May 15, 2023 | — held |
MORGAN STANLEY biological products, (no diagnostic substances) | 105.5K | 0.14% | 0.14% | $36.92M | Feb 14, 2023 | ▲ 13.9K |
NORTHERN TRUST CORP biological products, (no diagnostic substances) | 74.3K | 0.10% | 0.10% | $25.99M | Feb 13, 2023 | — held |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q4 2022 对比上季度
Q4 2022
7
增持
+86.3K 股9
新建仓
首次建仓4
减持
−127.1K 股8
清仓
完全退出净股数变化（前50家）
40.8K
+86.3K / −127.1K
净新增持仓人
+4
新建 9 个 / 退出 8 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
IDRA 内幕交易记录
数据来源：SEC Form 4
近期内部人员以卖出为主。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
0
买入笔数
4
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
GOWEN MAXINE director | Aug 10, 2023 | Sale | 51 | $0.51 | $26.01 | 0 | Form 4 ↗ |
MILANO VINCENT director | Aug 10, 2023 | Sale | 3,283 | $0.53 | $1.8K | 9.0K | Form 4 ↗ |
Pillar Invest Corp 10 percent owner | May 17, 2023 | Purchase | 26,965 | $1.42 | $38.3K | 170.7K | Form 4 ↗ |
Pillar Invest Corp 10 percent owner | Jul 12, 2023 | Sale | 3,605 | $1.58 | $5.7K | 167.1K | Form 4 ↗ |
Pillar Invest Corp 10 percent owner | Jul 13, 2023 | Sale | 2,213 | $1.54 | $3.4K | 164.9K | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 6,887 | $1.40 | $9.6K | 1.33M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 6,645 | $1.41 | $9.4K | 1.33M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 8,469 | $1.42 | $12.0K | 1.32M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 1,220 | $1.43 | $1.7K | 1.32M | Form 4 ↗ |
Chopra Atul 10 percent owner | May 15, 2023 | Sale | 3,369 | $1.44 | $4.9K | 1.31M | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Idera Pharmaceuticals, Inc.（IDRA）主要由机构投资者持有，机构持股比例约为 —。公司内部人员持股约 —，散户及公众持股约占剩余的 —。
Idera Pharmaceuticals, Inc. 最大机构股东为 SIMPLEX TRADING, LLC，截至 December 31, 2022 持有约 2,274 股，占总流通股的 6.98%。
目前共有 29 家机构持有 IDRA 股票，合计持仓市值约 $1,099,615，数据来源为最新 SEC 13F 申报。
常见问题
IDRA ownershipIdera Pharmaceuticals, Inc.（IDRA）主要由机构投资者持有，机构持股约 —。最大股东为 SIMPLEX TRADING, LLC，持股比例 6.98%。内部人员持股约 —。数据来源 SEC Form 13F，截至 December 31, 2022。